Advantage 100 mg Lösung zum Auftropfen auf die Haut für Hunde
Advantage 100 mg Lösung zum Auftropfen auf die Haut für Hunde
Authorised
- Imidacloprid
Product identification
Medicine name:
Advantage 100 mg Lösung zum Auftropfen auf die Haut für Hunde
Advantage 100 mg Lösung zum Auftropfen auf die Haut für Hunde
Active substance:
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Imidacloprid100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Cutaneous solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX17
Legal status of supply:
-
Medicinal product not subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Available in:
-
Austria
Package description:
- Pack sizes 1 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps
- Pack sizes 1 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
- Pack sizes 1 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
- Pack sizes 1 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
- Pack sizes 1 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00324
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0020/002
Concerned member states:
-
Denmark
-
Germany
-
Ireland
-
Italy
-
Netherlands
-
Norway
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 24/06/2021
German (PDF)
Published on: 28/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 28/02/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 28/02/2022
AT_V_0020_0001-004_PuAR_Advantage dogs_ua.pdf
English (PDF)
Download Published on: 31/08/2021
How useful was this page?: